Journal
NATURE IMMUNOLOGY
Volume 13, Issue 12, Pages 1178-+Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ni.2457
Keywords
-
Categories
Funding
- US National Center for Advancing Translational Sciences
- US National Center for Research Resources, US National Institutes of Health (NIH) [8UL1TR000043]
- St. Giles Foundation
- Jeffrey Modell Foundation
- Rockefeller University
- INSERM
- Paris Descartes University
- US National Institute of Allergy and Infectious Diseases [R21AI085523]
- NIH [5P01AI061093, R01AR050770]
- Canceropole Ile de France
- European Community Network of Excellence-Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation [LSHC-CT-2005-018683]
- Thrasher Research Fund
- Institut de Recherches Servier
- Manton Foundation
Ask authors/readers for more resources
We report the clinical description and molecular dissection of a new fatal human inherited disorder characterized by chronic autoinflammation, invasive bacterial infections and muscular amylopectinosis. Patients from two kindreds carried biallelic loss-of-expression and loss-of-function mutations in HOIL1 (RBCK1), a component of the linear ubiquitination chain assembly complex (LUBAC). These mutations resulted in impairment of LUBAC stability. NF-kappa B activation in response to interleukin 1 beta (IL-1 beta) was compromised in the patients' fibroblasts. By contrast, the patients' mononuclear leukocytes, particularly monocytes, were hyper-responsive to IL-1 beta. The consequences of human HOIL-1 and LUBAC deficiencies for IL-1 beta responses thus differed between cell types, consistent with the unique association of autoinflammation and immunodeficiency in these patients. These data suggest that LUBAC regulates NF-kappa B-dependent IL-1 beta responses differently in different cell types.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available